Attached files
file | filename |
---|---|
8-K - FORM 8K 3-3-2020 - Ainos, Inc. | form8k_03032020.htm |
Exhibit 16.1
United States Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentleman:
We have read the statements under Item 4.01 in the Form 8-K dated March 2, 2020, of Amarillo Biosciences, Inc. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We have no basis to agree or disagree with the other
statements made by the Company in the Form 8-K.
Sincerely,
/s/ LBB & Associates Ltd., LLP
LBB & Associates Ltd., LLP
Houston, Texas
March 3, 2020